Reference | Gender, Age | Involved sites | Intra-epithelial | Lamina propria |
---|---|---|---|---|
16 | F, 38 | Small intestine | 46%a | NR |
16 | F, 47 | Small intestine | 42%a | NR |
8 | F, 39 | Stomach, duodenum, jejunum, colon, recto-sigmoid | 12%a (normal), decreased CD3- CD103+, aberrant CD3+CD4+CD103-, increased HLA-II expression on CD3+ | Lympho-plasmacytic infiltrate (CD3+) |
19 | F, 50 | Duodenum, colon | Duodenum: IEL = 48/100, CD3 + 50/mm (elevated), eosinophils (some); Colon: normal | Colon: lympho-plasmacytic infiltrate, eosinophils (some) |
18 | F, 82 | Duodenum | Lympho-plasmacytic infiltrate | NR |
20 | M, 67 | colon | NR | NR |
20 | F, 39 | Small intestine, colon | NR | NR |
22 | F, 58 | Stomach, duodenum, jejunum, colon, rectosigmoid | Duodenum: IEL = 10-20/100, CD8 + preponderance Jejunum: lymphocytosis Colon: chronic inflammation, CD4 + , CD8 + , CD19 + /20 + , CD68 + | Duodenum: CD3+ and CD43+ lymphocytosis with CD68 + (macrophages) Jejunum: Inflammatory infiltrate |
15 | M, 54 | Duodenum, ileum | Duodenum: IEL = 28/100 (normal), 50% CD8 + , oligoclonal TCR αβ + Ileum: lymphocytosis Colon: lymphocytosis | NR |
3 | M, 19 | Duodenum, ileum, colon | Normal | NR |
17 | F, 35 | Duodenum | IEL = > 40/100 52% CD3+ | NR |
21 | M, 59 | Stomach, colon, ileum | Normal | Colon + Ileum: lympho-plasmacytic infiltrate, occasional neutrophils and eosinophils Stomach + Colon + Ileum: CD8 + and CD45RO + preponderance |
4 | M, 21 | Duodenum | IEL = 50/100 CD8+ preponderance | CD4+ preponderance, occasional CD8+ and neutrophils, rare CD20+ |
24 | M, 58 | Duodenum, ileum, colon | Lymphocytosis | Lympho-plasmacytic infiltrate |